Insufficient scRNA-seq data for expression of GBGT1 at single-cell level.
Insufficient scRNA-seq data for expression of GBGT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 816.27 | 653 / 653 | 100% | 5.51 | 602 / 605 |
breast | 100% | 692.53 | 459 / 459 | 97% | 4.09 | 1083 / 1118 |
ovary | 100% | 1212.47 | 180 / 180 | 97% | 3.78 | 415 / 430 |
lung | 100% | 1145.93 | 577 / 578 | 96% | 5.32 | 1111 / 1155 |
prostate | 100% | 808.85 | 245 / 245 | 95% | 3.07 | 477 / 502 |
kidney | 100% | 579.47 | 89 / 89 | 94% | 5.07 | 849 / 901 |
brain | 95% | 343.66 | 2505 / 2642 | 96% | 4.18 | 679 / 705 |
stomach | 100% | 1865.57 | 359 / 359 | 90% | 3.70 | 258 / 286 |
adrenal gland | 100% | 1161.92 | 257 / 258 | 87% | 5.13 | 201 / 230 |
intestine | 100% | 628.66 | 966 / 966 | 85% | 3.05 | 450 / 527 |
uterus | 100% | 741.26 | 170 / 170 | 83% | 3.40 | 380 / 459 |
bladder | 95% | 670.19 | 20 / 21 | 85% | 3.39 | 426 / 504 |
pancreas | 80% | 216.36 | 263 / 328 | 97% | 5.57 | 173 / 178 |
skin | 86% | 300.80 | 1556 / 1809 | 87% | 3.78 | 412 / 472 |
esophagus | 99% | 562.58 | 1434 / 1445 | 73% | 2.10 | 134 / 183 |
eye | 0% | 0 | 0 / 0 | 100% | 17.11 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.74 | 29 / 29 |
spleen | 100% | 1047.51 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 826.97 | 1198 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1385.09 | 920 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 475.94 | 847 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 415.80 | 1247 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 2.40 | 39 / 45 |
liver | 18% | 44.32 | 41 / 226 | 45% | 1.39 | 182 / 406 |
muscle | 48% | 94.50 | 384 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0030259 | Biological process | lipid glycosylation |
GO_0009247 | Biological process | glycolipid biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031982 | Cellular component | vesicle |
GO_0047277 | Molecular function | globoside alpha-N-acetylgalactosaminyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GBGT1 |
Protein name | Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group) Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (EC 2.4.1.-) (Forssman glycolipid synthase-like protein) |
Synonyms | UNQ2513/PRO6002 |
Description | FUNCTION: Has lost the ability to synthesize Forssman glycolipid antigen (FORS1/FG) . Might have acquired an alternative function in glycosphingolipid metabolism, but it remains to be established. It appears to have drifted more slowly than confirmed pseudogenes in the glycosyltransferase 6 family, suggesting that it has remained under evolutionary pressure. . |
Accessions | Q5T7U8 ENST00000372043.7 [Q8N5D6-2] J7Q261 ENST00000470431.5 J7PW20 J7Q2I4 ENST00000372038.7 ENST00000540636.6 [Q8N5D6-3] A0A2R8Y4A7 ENST00000644196.1 ENST00000646215.1 ENST00000372036.4 A0A2R8YGC1 ENST00000372040.9 [Q8N5D6-1] ENST00000487864.1 Q5T7V0 J7Q0Z1 Q8N5D6 J7Q1C6 |